SloveniaThe article discusses a groundbreaking study where scientists successfully reduced high cholesterol levels in patients by editing their genes using CRISPR-Cas9 technology. Instead of daily medication, researchers tested gene therapy on 15 patients with dangerously high cholesterol who had not responded to traditional treatments. The results showed a 50% reduction in cholesterol levels that lasted over a year without adverse effects. The findings were published in the prestigious journal *The New England Journal of Medicine* in November 2025. Researchers emphasized the potential of this approach, particularly for young individuals with severe cholesterol issues, as it could replace lifelong medication regimens. Experts highlighted the long-term effectiveness and safety of the treatment, suggesting it could revolutionize cardiovascular disease management.
Bias read (Center): While the topic relates to medical advancement and public health, which can have political implications, the article presents the scientific findings and expert opinions without overt ideological bias. It focuses on the clinical outcomes and potential societal impact rather than taking a partisan立场.
